Revenue
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Revenue | $25,000 | $125,000 | $108,000 | $90,683 | $68,613 | $59,061 | $112,497 |
| Research & development | $126.8M | $176.3M | $128.8M | $81.4M | $25.9M | $12.1M | $22.4M |
| Operating expenses | $155.9M | $192.1M | $150.4M | $96.7M | — | — | — |
| Operating income | −$155.8M | −$191.8M | −$150.0M | −$96.5M | — | — | — |
| Operating margin | −623,048.00% | −153,473.60% | −138,912.04% | −106,456.70% | — | — | — |
| EBITDA | −$155.8M | −$191.8M | −$150.0M | −$96.5M | — | — | — |
| EBITDA margin | −623,020.00% | −153,458.40% | −138,896.30% | −106,443.56% | — | — | — |
| Net income | −$162.8M | −$220.2M | −$142.5M | −$92.8M | −$45.3M | −$11.1M | −$15.0M |
| Net profit margin | −651,164.00% | −176,193.60% | −131,963.89% | −102,353.66% | −66,087.32% | −18,833.41% | −13,290.97% |
| Basic EPSper basic share | -$0.13 | -$0.35 | -$0.32 | -$0.26 | -$0.14 | -$0.04 | -$0.06 |
| Diluted EPSper diluted share | -$0.13 | -$0.35 | -$0.32 | -$0.26 | -$0.14 | -$0.04 | -$0.06 |
Reported shareholders